Nicolette Charles A.

Argos Therapeutics Inc

CSO and Vice President of R&D

Avg. Two Year Performance

(97%) Avg. Purchase Return (40%) Compound

No Sale Track Record

Holdings: 20.06K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Other

Other

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions